These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2783773

  • 1. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
    Houck KA, Michalopoulos GK, Strom SC.
    Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 3. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
    Longstreet M, Miller B, Howe PH.
    Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
    Serra R, Verderame MF, Isom HC.
    Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
    [Abstract] [Full Text] [Related]

  • 5. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Valverius EM, Walker-Jones D, Bates SE, Stampfer MR, Clark R, McCormick F, Dickson RB, Lippman ME.
    Cancer Res; 1989 Nov 15; 49(22):6269-74. PubMed ID: 2553252
    [Abstract] [Full Text] [Related]

  • 6. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G.
    J Cell Physiol; 1997 Aug 15; 172(2):200-8. PubMed ID: 9258341
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA.
    Anticancer Res; 1985 Aug 15; 5(5):485-98. PubMed ID: 3904595
    [Abstract] [Full Text] [Related]

  • 8. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
    Huber BE, Cordingley MG.
    Oncogene; 1988 Sep 15; 3(3):245-56. PubMed ID: 3060790
    [Abstract] [Full Text] [Related]

  • 9. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R.
    J Cell Physiol; 1987 Mar 15; 130(3):397-409. PubMed ID: 3494020
    [Abstract] [Full Text] [Related]

  • 10. Development of resistance to the growth inhibitory effects of transforming growth factor beta 1 during the spontaneous transformation of rat liver epithelial cells.
    Huggett AC, Ellis PA, Ford CP, Hampton LL, Rimoldi D, Thorgeirsson SS.
    Cancer Res; 1991 Nov 01; 51(21):5929-36. PubMed ID: 1718589
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture.
    McMahon JB, Richards WL, del Campo AA, Song MK, Thorgeirsson SS.
    Cancer Res; 1986 Sep 01; 46(9):4665-71. PubMed ID: 3089593
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of epithelial membrane antigen expression by transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Walker-Jones D, Valverius EM, Stampfer MR, Lippman ME, Dickson RB.
    Cancer Res; 1989 Nov 15; 49(22):6407-11. PubMed ID: 2680064
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD, Allen HL, Kraynak AR, Bradley MO.
    Oncogene; 1988 Feb 15; 2(2):141-7. PubMed ID: 3285293
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD, Stein RB, Sina JF, DeLuca JG, Allen HL, Bradley MO.
    Cancer Res; 1986 Mar 15; 46(3):1458-64. PubMed ID: 3510726
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K, Sheng H, Shao J, Beauchamp RD.
    Exp Cell Res; 2001 Jun 10; 266(2):239-49. PubMed ID: 11399052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.